Resolved
Resolved (by 6-0 with 1 abstention) to grant the application for reserved matters in accordance with the officer recommendation, for the reasons set out in the officer report, and subject to the conditions recommended by the officers.
Planning decided this item on Wednesday 4 February 2015. Below is the council's own wording, with the papers it was decided on.
Resolved
Resolved (by 6-0 with 1 abstention) to grant the application for reserved matters in accordance with the officer recommendation, for the reasons set out in the officer report, and subject to the conditions recommended by the officers.
PLANNING COMMITTEE Date: 4 February 2015
Application 14/1633/REM Agenda Number Item
Date Received 13 October 2014 Officer New Neighbourhoods Team
Target Date 12 January 2015
Ward Queen Edith's
Site Land to the West and South West of Addenbrooke’s Campus (AKA Cambridge Biomedical Campus) Robinson Way, Addenbrooke’s, Hills Road, Cambridge
Proposal Reserved matters application pursuant to outline approval 06/0796/OUT for a total of 59,821sqm (Gross External Area excluding plant) Biotech and Biomedical Research and Development floorspace, to include:
i) R&D Centre and Corporate Headquarters, ii) R&D Enabling Building, iii) Support Building and Energy Centre, iv) Associated car, motorbike and cycle parking, v) Hard and soft landscaping, vi)Internal roads, supporting facilities and ancillary infrastructure.
Applicant AstraZeneca SUMMARY The application is for a total of 59,821sqm Biotech and Biomedical Research and Development floorspace.
The development accords with the Development Plan for the following reasons:
The application is a reserved matters application pursuant to an outline permission. The proposed use, and floorspace are consistent with that outline approval.
The design of the development has been well considered with regard to its context and site constraints and is compatible with the other building and public realm designs coming forward within the Cambridge Biomedical Campus. The necessary mitigation measures, such as transport improvements have been secured through the outline consent and will be triggered as development such as this proposal come forward on the wider site. The large number of objections to the scheme is noted and these representations have been carefully considered in reaching this recommendation. None of the objections provide sufficient planning justification to depart from the approved development plan, and extant outline consent on the site.
RECOMMENDATION APPROVAL 1.0 SITE DESCRIPTION/AREA CONTEXT
1.1Addenbrooke’s Campus sits to the South of Cambridge and can be accessed via Long Road to the north, and the Hills Road/Fendon Road/Robinson Way Roundabout to the east. As part of strategic growth in the south of Cambridge outlined within the Cambridge Local Plan 2006 and subsequent Area Development Framework, access to the campus can also be reached from the south west via the Addenbrooke’s Road.
1.2The application site is split into two parts. The first plot (North Plot) sits to the west of the main Addenbrooke’s Campus and is almost triangular in shape with Francis Crick Avenue running along the north western edge, Robinson Way along the eastern edge, and the proposed ‘Circus’ open space located to the south.
1.3The second plot (South Plot) is almost rectangular in shape and bounds the existing Railway Line to the west, Francis Crick Avenue to the east and is situated close to the Cambridgeshire Guided Bus bridge to the north. To the south are undeveloped plots of land which are earmarked for further Biotech and Biomedical Research and Development floorspace.
1.4To the south of the North Plot and the east of the South plot lies an area of open space known as the ‘Circus’ which will comprise just under 3ha of open space as well as accommodating an extended route of the Guided Bus. Beyond this to the south lies land where permission has recently been granted for the New Papworth Hospital. To the east of the North Plot on the opposite side of Robinson Way consent has been granted for ‘The Forum’, an education centre, private hospital, hotel and conference centre.
1.5Both plots are part of the Addenbrooke’s 2020 land released from the Green Belt in the Cambridge Local Plan 2006, and approved through outline planning permission 06/0796/OUT for the following uses: clinical research and treatment, clinical in-patient treatment and biomedical and biotech research and development.
Pro opens the officer report behind each decision, searchable and quotable, across every council we cover.
PDF |
14/1633/REM : Land To The West And South West Of Addenbrookes CampusReport | 1.1 MB | DownloadRead as text |
Follow Planning at Cambridge and we tell you when its next papers are published, before the meeting rather than after it.
| Meeting | Decision | Outcome | |
|---|---|---|---|
| 4 Nov 2026 | 26/02186/FUL Coldham's Common, Pool Way, Whitehill RoadResolved (by 7 votes to 0) to grant the application for planning permission in accordance with the Officer recommenda... | Decided | Open |
| 24 Jun 2026 | 25/04187/FUL Hanover Court and Princess CourtResolved (by 4 votes to 3) to grant the application for planning permission in accordance with the Officer recommenda... | Agreed | Open |
| 24 Jun 2026 | 25/03323/FUL 73 Newmarket RoadResolved (4 votes to 4 – and on the Chair’s casting vote) to grant the application for planning permission in accorda... | Agreed | Open |
| 24 Jun 2026 | 26/01081/FUL 9, 11, 15 and 17 Ashfield RoadResolved (by 6 votes to 0) to grant the application for planning permission in accordance with the Officer recommenda... | Decided | Open |
| 24 Jun 2026 | 26/01400/FUL 1, 2, 3, 4, 11, 12 The GreenResolved (by 5 votes to 0) to grant the application for planning permission in accordance with the Officer recommenda... | Decided | Open |
We use a cookie to keep you signed in and run your free-paper allowance, and an optional one to count visits. You can accept all, or choose. Privacy & cookies
Keeps you signed in and runs your free-paper allowance. Always on.
Counts visits and which pages are used. First-party only, no advertising, never shared.